Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-05-08 15:00 Tx date 2024-05-06 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+128,770 vol |
453,624 | |
Filed 2023-12-20 19:11 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,668 vol |
324,854 | |
Filed 2023-07-14 19:50 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,668 vol |
283,186 | |
Filed 2023-07-14 19:49 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+208,334 vol |
241,518 | |
Filed 2023-07-14 19:32 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+21,357 vol |
21,357 | |
Filed 2023-07-14 19:32 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-128,138 vol |
0 | |
Filed 2023-07-14 19:32 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+33,184 vol |
33,184 | |
Filed 2023-07-14 19:31 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-199,100 vol |
0 | |
Filed 2022-09-13 16:56 Tx date 2022-09-09 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
199,100 | ||
Filed 2022-09-13 16:55 Tx date 2022-09-09 |
$ACST
Acasti Pharma Inc. |
Kohli, Prashant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
128,138 |